-transparent.png){kind=logo}
Lipid disorders, also known as dyslipidaemias, are abnormalities of lipoprotein metabolism and include elevations of total cholesterol, low density lipoprotein (LDL) cholesterol, and triglyceride, and reductions in high density lipoprotein (HDL) cholesterol, and can be acquired or familial in nature. Dyslipidaemia is a major risk factor for coronary heart disease and cardiovascular disease (CVD), which is the leading cause of morbidity and mortality in Australia. Dyslipidaemia is defined by laboratory testing and using statistically determined criteria. Although the benefits of detecting and treating dyslipidaemia in patients with known CVD is clear, controversy remains regarding screening asymptomatic individuals who are not known to be at increased cardiovascular risk. This review examines the role of screening in the detection and treatment of individuals with lipid disorders.
Damon A Bell, and
Amanda J Hooper, and
Robert Bender, and
Glenn Edwards, and
Frank M van Bockxmeer, and
Gerald F Watts, and
John R Burnett
June 2024,
Current opinion in lipidology,
Damon A Bell, and
Amanda J Hooper, and
Robert Bender, and
Glenn Edwards, and
Frank M van Bockxmeer, and
Gerald F Watts, and
John R Burnett
July 2012,
Pediatric annals,
Damon A Bell, and
Amanda J Hooper, and
Robert Bender, and
Glenn Edwards, and
Frank M van Bockxmeer, and
Gerald F Watts, and
John R Burnett
December 2009,
American family physician,
Damon A Bell, and
Amanda J Hooper, and
Robert Bender, and
Glenn Edwards, and
Frank M van Bockxmeer, and
Gerald F Watts, and
John R Burnett
April 2001,
American journal of preventive medicine,
Damon A Bell, and
Amanda J Hooper, and
Robert Bender, and
Glenn Edwards, and
Frank M van Bockxmeer, and
Gerald F Watts, and
John R Burnett
November 2016,
JAMA,
Damon A Bell, and
Amanda J Hooper, and
Robert Bender, and
Glenn Edwards, and
Frank M van Bockxmeer, and
Gerald F Watts, and
John R Burnett
October 2017,
American family physician,
Damon A Bell, and
Amanda J Hooper, and
Robert Bender, and
Glenn Edwards, and
Frank M van Bockxmeer, and
Gerald F Watts, and
John R Burnett
July 2023,
JAMA,
Damon A Bell, and
Amanda J Hooper, and
Robert Bender, and
Glenn Edwards, and
Frank M van Bockxmeer, and
Gerald F Watts, and
John R Burnett
April 2001,
American journal of preventive medicine,
Damon A Bell, and
Amanda J Hooper, and
Robert Bender, and
Glenn Edwards, and
Frank M van Bockxmeer, and
Gerald F Watts, and
John R Burnett
April 1993,
The New England journal of medicine,
Damon A Bell, and
Amanda J Hooper, and
Robert Bender, and
Glenn Edwards, and
Frank M van Bockxmeer, and
Gerald F Watts, and
John R Burnett
January 2002,
American family physician,
